Report Events

[Registration Closed] (Webinar) The 90th HGPI Seminar – Examining the ideal vaccination system for Japan and current efforts of the Expert Council on Promotion of Vaccination (November 12, 2020)

[Registration Closed] (Webinar) The 90th HGPI Seminar – Examining the ideal vaccination system for Japan and current efforts of the Expert Council on Promotion of Vaccination (November 12, 2020)

Recently, interest in immunization and finding the best way of providing vaccines is growing worldwide in response to the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The vaccination system in Japan is based on the Immunization Act which was enacted in 1948. After its enactment, vaccinations were carried out for twelve infectious diseases including smallpox and pertussis to help prevent the outbreak or spread of infectious diseases. Those efforts promoted public health and contributed to the economic development of Japan.

Vaccination is considered one of the most cost-effective public health interventions because it not only contributes to public health, it also benefits society, the economy, and education. However, the World Health Organization (WHO) has reported that Vaccine Preventable Diseases (VPDs) infect 1.5 million people every year. Another issue is vaccine hesitancy, which occurs when people with access to vaccines refuse to be vaccinated due to negative attitudes towards vaccines.

In recent years, vaccine hesitancy has grown to be a significant issue both domestically and abroad. In Japan, there have been numerous cases in which the public or society has responded in a hypersensitive manner towards vaccination over concerns regarding the side effects of vaccines or because of insufficient communication from central or local governments and companies conducting vaccinations. One such example occurred when policy promoting HPV vaccination was reconsidered over reports and lawsuits concerning the human papillomavirus (HPV) vaccine.

When considering which immunization practices are most suitable in the future, in addition to news reports on vaccine side effects and changes in attitudes throughout society caused by pandemics and other events, it will also be necessary to take into account new scientific discoveries, the development of new manufacturing technologies, changes in methods used to communicate information on healthcare, and changes in individuals’ daily habits and lifestyles. It will also be important to include all of society in discussions on the ideal methods of implementing a vaccination system that will provide the right vaccines at the right times over the entire life course to all generations after ensuring all parties have a clear understanding of vaccines’ risks and benefits for society and each individual.

To help build social momentum for and to contribute to immunization and vaccination policy and public health in Japan, HGPI brought together an advisory board in FY2020 that includes experts from industry, government, academia, and civil society to advance discussions on this topic. For the 90th HGPI Seminar, we will host Professor Satoshi Iwata, a member of our advisory board and Chairman of the Expert Council on Promotion of Vaccination, a committee of specialists from relevant academic societies in Japan. Professor Iwata’s activities aim to contribute to establishing a system in Japan that will provide the necessary vaccinations to people of all ages in a safe and appropriate manner. Professor Iwata will introduce his current efforts, provide information on the current situation surrounding immunization and vaccination policy, and share his outlook for the future. 

*Please note that this seminar is available in Japanese only.

■Speaker
Prof. Satoshi Iwata (Chairman, Expert Council on Promotion of Vaccination; Department of Infectious Diseases, National Cancer Center Hospital)

■ Date & Time
Thursday, November 12, 18:30-19:45

■ Venue
Zoom Webinar

■ Participation Fee
Free

■Capacity
500 attendees

■ Profile
Prof. Satoshi Iwata (Chairman, Expert Council on Promotion of Vaccination; Department of Infectious Diseases, National Cancer Center Hospital)
Professor Satoshi Iwata graduated from Keio University School of Medicine in 1976. That same year, he joined the Department of Pediatrics at Keio University School of Medicine. Later, he studied at St. Louis University and Columbia University in the United States for a brief period in 1996. After returning to Japan, he assumed the post of Chief Pediatrician at Tokyo Medical Center in 1999. His other roles at Tokyo Medical Center have included Director of Education and Training, Director of General Medical Services, Director of Medical Safety Management, and Director of the Clinical Trial Management Office. In 2010, he became a professor at Keio University School of Medicine’s Division of Infectious Diseases and Infection Control. In 2013, he became a professor at the Keio University School of Medicine’s Department of Infectious Diseases. He has served as Director of the Department of Infectious Diseases at the National Cancer Center Hospital since 2017 and as Visiting Professor at Keio University School of Medicine since 2018.


Registration will close at 10:00 on Tuesday, November 10, 2020. Participants will be selected by a draw of lots and informed of the results by Tuesday, November 10. Individual supporting members of HGPI will be notified earlier.
After registration has been completed, a confirmation email will be automatically sent. If you do not receive a confirmation email, please contact HGPI by email at info@hgpi.org or by phone at 03-4243-7156.
In the event that you would like to cancel your registration, please inform us by noon on Wednesday, November 11.

Back to Events
PageTop